Finversia.ru20 дн.
FDA одобрило препарат Amgen для лечения наиболее опасного вида рака легких
Управление по санитарному надзору за качеством пищевых продуктов и лекарственных препаратов (FDA) одобрило терапию Amgen для больных с ...
Drug Store News2 дн.
FDA approves Amgen's Soliris biosimilar
Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...
Reuters20 дн.
US FDA approves Amgen drug for small cell lung cancer
May 16 (Reuters) - (This May 16 story has been officially corrected by Amgen to change the pricing estimate in paragraph 4) The U.S. Food and Drug Administration on Thursday granted accelerated ...
rbc2 г. (лет)
FDA одобрило препарат компаний AstraZeneca и Amgen для лечения астмы
Управление по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA) США одобрило препарат тезпир компаний AstraZeneca и Amgen для ...
The Globe and Mail21 дн.
U.S. FDA approves Amgen drug for small cell lung cancer
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen’s tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
U.S. News & World Report20 дн.
FDA Approves New Drug for Deadly Lung Cancer
FRIDAY, May, 17, 2024 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly ...
headtopics17 дн.
FDA Approves New Drug for Deadly Lung Cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. The U.S. Food and Drug Administration on Thursday approved a new ...
healthday20 дн.
FDA Approves New Drug for Deadly Lung Cancer
FRIDAY, May, 17, 2024 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab ...
Medical Xpress21 дн.
FDA approves new drug for deadly lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for patients who ...
scrippsnews7 мес.
FDA approves new weight loss drug from the makers of Mounjaro
The U.S. Food and Drug Administration approved Zepbound, a new weight loss drug from pharmaceutical company Eli Lilly, on Wednesday. Zepbound is a once-weekly injectable medication with an active ...